Editorial Team

.
Editor-in-Chief
Peter Black, MD, FACS, FRCSC
Canada

Urologic Oncologist at Vancouver General Hospital
Senior Research Scientist, Vancouver Prostate Centre
Associate Director, Clinical Research, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, University of British Columbia
Area of Expertise: Urologic Cancers, Bladder, and Prostate Cancer.
Peter Black
Associate Editors
Thomas Herrmann, MD, FEBU
Switzerland
Thomas Herrmann
Kathleen Kobashi, MD, FACS
United States
Kathleen Kobashi
Philippe Spiess, MD, MS, FACS, FRCSC
United States
Philippe Spiess
Henry Woo, MBBS, DMedSc, FRACS (Urol)
Australia
Henry Woo

Social Media Editor
Jeremy Y. C. Teoh, MBBS, FRCSEd, FCSHK, FHKAM
Hong Kong SAR
Statistical Editor
Alice Dragomir, MSc, PhD
Canada
ICUD Editor
Luc Valiquette, MD, FRCSC
Canada

Innovators Editor
Amanda Chung, BSc (Med) / MBBS, MS, FRACS (Urology)
Australia
Regional Editors
Edmund Chiong, MBBS, PhD, FRCSEd, FRCSI, FAMS (Urology)
Singapore
Sandro Esteves, MD, MSc, PhD
Brazil
Tamsin Greenwell, MD, FRCS (Urol)
United Kingdom
Yasser Osman, MBBCh, MSc, MD
Egypt
Danny Rabah, MBBS, FRCSC, FACS
Saudi Arabia
Sanjay Sinha, MCh
India
Roman Sosnowski, FEBU
Poland

Managing Editor
Jane Fairbanks
Canada
Peter Black

Peter Black

MD, FACS, FRCSC

Peter Black is a Urologic Oncologist at Vancouver General Hospital, a Research Scientist at the Vancouver Prostate Centre, and Professor in the Department of Urologic Sciences at the University of British Columbia. He received his undergraduate degree from the University of British Colombia in Vancouver and his medical degree from Johannes Gutenberg University in Mainz, Germany (1997). He completed his urologic training at the University of Washington in Seattle (2005) and fellowship in urologic oncology at M.D. Anderson Cancer Center in Houston, Texas (2008). Peter has a clinical subspecialty interest in bladder and prostate cancer. He also maintains a grant-funded translational research program in urothelial carcinoma with a focus on mechanisms of resistance to chemotherapy and novel targeted therapies for bladder cancer. He previously served on the Board of Directors of the Société Internationale d’Urologie and is currently General Secretary of the International Bladder Cancer Network. He previously acted as Associate Editor for European Urology Focus, Assistant Editor for Urologic Oncology and Associate Editor for World Journal of Urology.

 
Kathleen Kobashi

Kathleen Kobashi

MD, FACS

Kathleen Kobashi, MD, FACS is Head of the Section of Urology and Renal Transplantation at Virginia Mason Medical Center and Director of VM’s Pelvic Floor Center. She received her BA at Wellesley College and her MD at Hahnemann University in Philadelphia, and completed her urologic residency at the University of California, Irvine, followed by a Female Pelvic Medicine and Reconstructive Surgery (FPMRS) fellowship at Cedars-Sinai in Los Angeles before joining Virginia Mason in 1999.

In addition to her passion around clinical medicine, Dr. Kobashi is dedicated to research and education of patients and future urologists. She founded the VM FPMRS fellowship in 2003 and a new urology residency in 2014, for which she serves as the Program Director. She is a Clinical Professor at the University of Washington in Seattle.

Dr. Kobashi has authored more than 100 peer-reviewed articles and book chapters on topics related to urinary incontinence and pelvic prolapse and has been invited faculty on the subject around the globe. She is the Immediate Past President of SUFU (Society for Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction), President-elect for the Western Section AUA, and serves on the American Board of Urology Examination Committee and as the Associate Editor of the new AUA journal, Urology Practice. She received the 2006 Continence Care Champion award from the National Association for Continence, the prestigious Paul Zimskind Award from SUFU in 2010, and a Presidential Citation from the American Urological Association in 2013.

 
Thomas Herrmann

Thomas Herrmann

MD, FEBU

PD Dr. med. Thomas Reinhard William Herrmann is Clinical Director Urology Spital Thurgau AG, Chairman Department of Urology, Kantonspital Frauenfeld, Switzerland.

Dr. Herrmann attended the Georg August University of Göttingen, Germany, and the University of Vienna, Austria. He received his medical degree in 2000. He completed his urology residency at Heinrich Heine University, Düsseldorf, Germany and Hanover Medical School in 2006 under the direction of Prof. Rolf Ackermann, Prof. Udo Jonas and Prof. Markus A. Kuczyk. In 2003, he completed a six-month fellowship in endourology, minimally invasive surgery and kidney transplantation at the Muljibhai Patel Urological Hospital in Nadiad, India, under the direction of Dr. Mahesh Desai. In 2013, he graduated with a professorial thesis at the Hanover Medical School.

His research interests focus on laser soft tissue surgery of the prostate and bladder, and he developed Thulium laser-assisted anatomical enucleation of the prostate and transurethral anatomical en bloc resection of bladder tumors. He also has a deep interest in bipolar current applications in endourology, specifically bipolar enucleation of the prostate and the development of novel tools for surgery in that field. In addition, he has conducted research in the field of laparoendoscopic single site surgery in transumbilical technique as well as minimally invasive percutaneous nephrolithotomy.

Dr. Herrmann has published in national and international journals and has presented his research at international conferences. He has been invited to live surgery meetings on multiple occasions.

Dr. Herrmann is Associate Editor of the World Journal of Urology and Editor of the SpringerPlus Urology Collection. He is also on the Editorial Board of Asian Journal of Andrology and is a reviewer for multiple international journals including European Urology, the Journal of Endourology, Asian Journal of Andrology, World Journal of Urology, and Urology.

 
Philippe E. Spiess

Philippe E. Spiess

MD, MS, FACS, FRCSC

Dr. Spiess is a senior member in the Department of Genitourinary Oncology, with dual appointment in the Department of Tumor Biology at the Moffitt Cancer Center and Research Institute, and is a full professor in the Department of Urology at the University of South Florida. Dr. Spiess serves as the assistant chief of surgical services and the Director of Virtual Health at the Moffitt Cancer Center. He completed his urology residency at McGill University in Montreal, Canada, and completed a 3-year urologic oncology fellowship at The University of Texas M.D. Anderson Cancer Center in Houston, Texas. Dr. Philippe Spiess’ clinical and research interests are in the field of penile and kidney cancer, and he is part of several research study collaborations on national and international levels. Dr. Spiess has published over 280 peer-reviewed manuscripts and has edited 5 textbooks in urologic oncology. He currently serves as the vice-chair of the National Comprehensive Cancer Network panel on bladder and penile cancer and sits on several international editorial boards including Urologic Oncology: Seminars and Original Investigations, BJU International, World Journal of Urology, Nature Reviews Urology, Canadian Journal of Urology, and the International Brazilian Journal of Urology. Dr. Spiess serves as the chair of the American Urological Association core curriculum of education. He has been invited to deliver numerous lectures both nationally and internationally.

 
Henry Woo

Henry Woo

MBBS, DMedSc, FRACS (Urol)

Professor Henry Woo is a urological surgeon with a subspecialized clinical practice in prostate surgery. He has published widely on benign prostatic hyperplasia and prostate cancer and has an international reputation for his work in the field. He is the Foundation Professor of Surgery at the Sydney Adventist Hospital Clinical School of the University of Sydney, as well as Head of the Department of Urology at the Sydney Adventist Hospital. Until 2012, Dr Woo was a visiting surgeon at Westmead Hospital and was associated with the Western Clinical School of the University of Sydney. Since 2016, he has also been the Director of Uro-Oncology and Professor of Robotic Cancer Surgery at the Chris O’Brien Lifehouse Comprehensive Cancer Centre. He is currently an Associate Editor of the Springer Nature-owned journal, Prostate Cancer and Prostatic Diseases, and is on the Editorial Boards of several journals, including European Urology, BJU International, Asian Journal of Urology, Prostate International, World Journal of Men’s Health, and World Journal of Urology. He is a Board Director of Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), as well as the charitable Australasian Urological Foundation (AUF). He is a Fellowship Elected Councillor of the Royal Australasian College of Surgeons (RACS).

 
Jeremy Y. C. Teoh

Jeremy Y. C. Teoh

MBBS, FRCSEd, FCSHK, FHKAM

Jeremy Teoh is a urologist and is currently an Assistant Professor of the Chinese University of Hong Kong. He is the founder of the UroSoMe (Urology Social Media) working group and he believes that social media plays an important role in the modern era of medicine. His research work is focused in studying the tumour heterogeneity and molecular subtypes of bladder cancer, and he has particular interest in en bloc resection of bladder tumour and robotic cystectomy. Jeremy has received numerous research grants with a total funding of more than USD 4 million. He has published more than 100 articles in peer-reviewed journals such as European Urology, Journal of Urology and BJU International. He has also been a regular reviewer for more than 30 journals. He is the Chairperson of the Younger Fellows Chapter of the College of Surgeons of Hong Kong, and he has been the Director of the Lions Kidney Educational Centre & Research Foundation since 2016.

 
Alice Dragomir

Alice Dragomir

MSc, PHD

Dr. Dragomir is an Associate Professor in the Faculty of Medicine at McGill University, and a scientist in health economics and outcomes research at the Research Institute of the McGill University Health Centre. She is also an Adjunct Professor at the Faculté de pharmacie of Université de Montréal. In 2016, she received Chercheur boursier FRQS Junior 1. Dr. Dragomir is a health economist and biostatistician with a master’s degree in statistics and a doctoral degree in pharmacoepidemiology and pharmacoeconomics from University of Montreal, Canada. She has 19 years of experience in academic research. She has been involved in research projects focused on evaluation of health outcomes and health economics related to different treatment strategies, adherence to treatments, health services utilization and disease modeling in several fields, such as hypertension, dyslipidemia, cardiovascular diseases, osteoporosis, mental health diseases, and cancers. Her current research is focused on clinical and economic evaluation of different treatment strategies offered to patients with urological cancers. Since 2015, she has been an economic lead for the Canadian Agency for Drugs and Technologies in Health economic evaluations. She has extensive experience in analyzing administrative healthcare databases, such as RAMQ and Med-Echo. Her research represents a valuable tool for decision-makers and clinician leaders when evaluating the clinical and economic impacts of innovative treatments.

 
Edmund Chiong

Edmund Chiong

MBBS (Singapore), PhD, FRCSEd, FRCSI, FAMS (Urology)

Edmond Chiong is Head & Senior Consultant, Department of Urology, University Surgical Cluster, National University Hospital, and Senior Consultant, Division of Surgical Oncology, National University Cancer Institute, Singapore. Dr Chiong graduated with the degrees of Bachelor of Medicine and Surgery from the National University of Singapore in 1995. He completed surgery fellowships in Edinburgh and Ireland, and completed his urology specialist training in Singapore. He subsequently completed a 2-year clinical fellowship program in urologic oncology at the University of Texas MD Anderson Cancer Center in Houston. He is also certified by the Society of Urologic Oncology, USA. His areas of particular interest are uro-oncology (prostate cancer, kidney cancer, bladder cancer, testicular cancer and penile cancer), prostate cancer high-dose rate brachytherapy, and Da Vinci robotic surgery. Dr Chiong is an investigator in a number of grantfunded, clinical and basic science research projects. He also runs a number of clinical trials in bladder and prostate cancer. He has authored or co-authored papers in peer-reviewed journals and presented more than 120 abstracts at regional or international scientific meetings. He is also a reviewer for many leading international urology and cancer journals.

 
Roman Sosnowski

Roman Sosnowski

FEBU

Roman Sosnowski has been working for almost twenty years at The Uro-oncology Department at the Cancer Memorial Hospital, Maria Curie-Skłodowska in Warsaw, Poland. His main areas of interest include surgical treatments related to the bladder, the kidneys and prostate cancer but also testicular and penile cancer. He undertook clinical fellowships at some of the leading urological institutions in Denmark, Germany, Canada, and the United States. Recently he has been involved with a multi-centre collaboration across Europe, mainly with The European Association of Urology network. He has an interest in health awareness and prophylactics and, for more than ten years, has collaborated with patients, organizations, and institutions that support education, organizing content for their seminars, publications, and websites, and delivering lectures on a variety of topics related to urology. Recently he received diploma of Associated Professor mainly due to his scientific work focus on quality of life in uro-oncology. He is the author of many scientific papers and podium presentations.

 
Sandro Esteves

Sandro Esteves

MD, PhD

Sandro Esteves is the Founder and Medical Director of the ANDROFERT Andrology & Human Reproduction Clinic, in Campinas, Brazil. He received his Master’s in Surgery from the University of Campinas Medical School and his PhD in Urology from the Federal University of São Paulo Medical School. His post-doctoral training was at the American Center for Reproductive Medicine at the Cleveland Clinic. Dr. Esteves is one of the top three world experts in male infertility, azoospermia, varicocele, and sperm retrieval techniques. His cutting-edge research focuses on the relationship between the treatment of male infertility conditions and assisted reproductive technology outcomes. He is the author of 10 textbooks in the fields of infertility and reproductive medicine and has published in journals including The Lancet, Nature Reviews Urology, Human Reproduction Update, Journal of Urology, Human Reproduction, Fertility and Sterility, Urology, and Andrology. Dr. Esteves is an Associate Editor of Frontiers in Endocrinology (Reproduction) and International Brazilian Journal of Urology, and sits on the editorial boards of a dozen of peer-reviewed scientific journals.

 
Tamsin Greenwell

Tamsin Greenwell

MD, FRCS (Urol)

Ms Tamsin Greenwell is a Consultant Urologist at University College Hospital London and an Honorary Associate Professor at University College London. She is the Clinical Lead for the Female, Functional and Restorative (FFR) Urology Unit. Since her appointment in 2002 she has developed a practice which is entirely confined to FFR urology. Her main interests are vesicovaginal and other urinary tract fistulae, female urethral diverticulum, male and female urethral stricture, complex male and female urinary incontinence and lower urinary tract reconstruction. She runs a large multidisciplinary service with collaborative working with her urogynaecological and colorectal colleagues.

She has been the Chairman of the BAUS section of Functional, Neurourology and Urodynamics, the BAUS Director of Education and the RCS(Eng) Urology Tutor. She was the Clinical Lead for the development of Specialist Commissioning for Mesh Complications services and for Vesico-Vaginal Fistula services, and has been the BAUS liaison on the development of Specialist Commissioning for Recurrent Urinary Incontinence and Prolapse services. She has over 100 peer-reviewed publications and 16 chapters and books.

 
Yasser Mohamed Osman Shahin

Yasser Mohamed Osman Shahin

MBBCh, MSc, MD

Dr Yasser Osman is a consultant renal transplant surgeon, Professor of Urology, Urology & Nephrology Center, Mansoura University, where he has participated in the clinical as well as the academic activities of his institute for the last 20 years. He has a special interest in uro-oncology and endourology, as well as renal transplantation. He joined the center as a resident in urology in 1994, becoming an assistant lecturer in urology after completing his master’s degree in 1998, and becoming a lecturer after presenting his thesis on renal transplantation in 2003. In this period, Professor Osman visited the Mayo Clinic, the Cleveland Clinic, and the Memorial Sloan-Kettering Cancer Center in USA as an international scholar. Dr Osman has presented at more than 110 local and international meetings and has shared in and directed 42 workshops inside and outside the country by lecturing, performing live surgery and guiding animal laboratory surgeries. Dr Osman is a member of the Egyptian, American, and European urological associations, and he was honored by receiving 8 different national and international prizes crowned by the state prize in the field of surgery in 2003 and again in 2009. He has had 85 scientific papers published in peer-reviewed scientific International journals and has shared in the authorship of 3 book chapters. Dr Osman is a reviewer for 26 international scientific journals in the fields of urology and renal transplantation.

 
Danny M. Rabah

Danny M. Rabah

MBBS, FRCSC, FACS

Danny M. Rabah is a urologic oncologist at King Saud University Medical City, Director of its Prostate Cancer Research Chair, and Professor in the Department of Surgery at King Saud University Riyadh, Saudi Arabia. He received his medical degree from King Saud University in 1996. He completed his urologic training at McGill University in Montreal, Canada, in 2002, a fellowship in Endourology and Minimally invasive surgery at Eastern Virginia medical school in Norfolk, Virginia, in 2003, and a further fellowship in urologic oncology at Memorial Sloan Cancer Center in New York in 2004. Danny has a clinical subspecialty interest in Kidney and prostate cancer. He previously served as chairman of the Department of Surgery at KSU and on the Board of Directors of the Arab Board of Urology and the Saudi Board of Urology. He is an Associate Editor for Journal of Nature and Science of Medicine and an editor at Urology Annals.

 
Sanjay Sinha

Sanjay Sinha

MCh

Sanjay Sinha is Honorary Professor and Consultant Urologist at Apollo Hospitals, Hyderabad, India. He has a specific interest in Lower Urinary Tract Dysfunction and Urinary Incontinence. Dr Sinha received his MBBS and MS from the Institute of Medical Sciences, Banaras Hindu University, and completed his training in Urology at the Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, in 1995. He is Associate Editor (Voiding Dysfunction Section) BMC Urology and is on the Editorial Board of the Indian Journal of Urology, International Urogynecology Journal, and Current Bladder Dysfunction Reports. He is Chair for the Urological Society of India Guidelines on ‘Urinary Incontinence’ and is a contributor to the chapter on urodynamics in the forthcoming 7th International Consultation on Incontinence. He is a member of the International Continence Society Good Urodynamics Practices Panel on Pressure-flow Studies. He has published over 50 articles in peer-reviewed journals and 10 chapters in textbooks.

 
Amanda Chung

Amanda Chung

MBBS, MS, FRACS (Urology)

Dr Amanda Chung completed her medical degree (BSc (Med) / MBBS) at the University of New South Wales in 2007, Master of Surgery (MS) at the University of Sydney in 2012, and became a Fellow of the Royal Australasian College of Surgeons in 2016. Furthermore, she completed a Fellowship of the Society of Genitourinary Reconstructive Surgeons (Eastern Virginia Medical School, Norfolk VA, USA) in 2017. She is a Member of the Urological Society of Australia and New Zealand. She combines her clinical work with research and is also currently undertaking a PhD through the University of Sydney. Her main research topic is “Detrusor ultrastructural studies in geriatric lower urinary tract dysfunction: correlation of features and development of a standardised protocol.” She also has research interests in reconstructive urology, functional urology and neuro-urology. Dr Amanda Chung has been the author or co-author of over 20 peer reviewed publications. She is credited with almost 100 peer-reviewed meeting abstracts, presentations and invited speaking appearances in both local and international conferences.

 
Jane Fairbanks

Jane Fairbanks

Originally from England, Jane studied English and editing at Simon Fraser University, graduating from the Publishing and Writing Program. After many years as a freelance editor and proofreader for journals in a range of specialties, she spent more than a decade as Assistant Editor at Journal of Obstetrics and Gynaecology Canada. She has also worked as a writer and editor with local and international humanitarian organizations.